The results of surgery for renal cell carcinoma metastases of the pancreas

References

• Padala SA, Barsouk A, Thandra KC, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79–87. doi: 10.14740/wjon1279.
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA A Cancer J Clinicians. 2022;72(1):7–33. doi: 10.3322/caac.21708.
   PubMed Web of Science ®Google Scholar
• Ballarin R, Spaggiari M, Cautero N, et al. Pancreatic metastases from renal cell carcinoma: the state of the art. WJG. 2011;17(43):4747e56. doi: 10.3748/wjg.v17.i43.4747.
   Web of Science ®Google Scholar
• Bianchi M, Sun M, Jeldres C, et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol. 2012;23(4):973–980. doi: 10.1093/annonc/mdr362.
   PubMed Web of Science ®Google Scholar
• Sperti C, Pozza G, Brazzale AR, et al. Metastatic tumors to the pancreas: a systematic review and metaanalysis. Minerva Chir. 2016;71(5):337–344.
   PubMed Web of Science ®Google Scholar
• Wiechno P, Kucharz J, Sadowska M, et al. Contemporary treatment of metastatic renal cell carcinoma. Med Oncol. 2018;35(12):156. doi: 10.1007/s12032-018-1217-1.
   PubMed Web of Science ®Google Scholar
• Kalra S, Atkinson BJ, Matrana MR, et al. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases. BJU Int. 2016;117(5):761–765. doi: 10.1111/bju.13185.
   PubMed Web of Science ®Google Scholar
• Sun M, Meyer CP, Karam JA, et al. Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy. Eur J Surg Oncol. 2018;44(9):1439–1445. doi: 10.1016/j.ejso.2018.05.026.
   PubMed Web of Science ®Google Scholar
• Palumbo C, Pecoraro A, Knipper S, et al. Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: a combined population-based analysis. Anticancer Res. 2019;39(8):4357–4361. doi: 10.21873/anticanres.13604.
   PubMed Web of Science ®Google Scholar
• Wu K, Liu Z, Shao Y, et al. Nomogram predicting survival to assist decision making of metastasectomy in patients with metastatic renal cell carcinoma. Front. Oncol. 2020;10:592243. doi: 10.3389/fonc.2020.592243.
   PubMedGoogle Scholar
• Jaen-Torrejimeno I, Rojas-Holguin A, Lopez-Guerra D, et al. Pancreatic resection for metastatic renal cell carcinoma. A systematic review. HPB . 2020;22(4):479–486. doi: 10.1016/j.hpb.2019.10.017.
   PubMed Web of Science ®Google Scholar
• Anderson B, Williams GA, Sanford DE, et al. A 22-year experience with pancreatic resection for metastatic renal cell carcinoma. HPB. 2020;22(2):312–317. doi: 10.1016/j.hpb.2019.05.019.
   PubMed Web of Science ®Google Scholar
• Shin TJ, Song C, Jeong CW, et al. Metastatic renal cell carcinoma to the pancreas: clinical features and treatment outcome. J Surg Oncol. 2021;123(1):204–213. doi: 10.1002/jso.26251.
   PubMed Web of Science ®Google Scholar
• Young J, Thompson A, Tait I, et al. Centralization of services and reduction of adverse events in pancreatic cancer surgery. World J Surg. 2013;37(9):2229–2233. doi: 10.1007/s00268-013-2108-4.
   PubMed Web of Science ®Google Scholar
• Krautz C, Nimptsch U, Weber GF, et al. Effect of hospital volume on in- hospital morbidity and mortality following pancreatic surgery in Germany. Ann Surg. 2018;267(3):411–417. doi: 10.1097/SLA.0000000000002248.
   PubMed Web of Science ®Google Scholar
• Morera-Ocon JF, Sabater-Orti L, Muñoz-Forner E, et al. Considerations on pancreatic exocrine function after pancreaticoduodenectomy. WJGO. 2014;6(9):325–329. 15doi: 10.4251/wjgo.v6.i9.325.
   Google Scholar
• Hua J, He Z, Qian D, et al. Duct-to-Mucosa versus invagination pancreaticojejunostomy following pancreaticoduodenectomy: a systematic review and meta- analysis. J Gastrointest Surg. 2015;19(10):1900–1909. doi: 10.1007/s11605-015-2913-1.
   PubMed Web of Science ®Google Scholar
• Leibovich BC, Blute ML, Cheville JC, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003;97(7):1663–1671. doi: 10.1002/cncr.11234.
   PubMed Web of Science ®Google Scholar
• Clavien PA, Barkun J, De Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: 5-year experience. Ann Surg. 2009;250(2):187–196. doi: 10.1097/SLA.0b013e3181b13ca2.
   PubMed Web of Science ®Google Scholar
• Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the international study group of liver surgery. Surgery. 2011;149(5):680e8–68688. doi: 10.1016/j.surg.2010.12.002.
   Web of Science ®Google Scholar
• Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the international study group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surg. 2017;161:584–e91.
   PubMed Web of Science ®Google Scholar
• Mathew G, Agha R, Albrecht J, et al. Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Ann Med Surg . 2021;72:103026. doi: 10.1016/j.amsu.2021.103026.
   PubMed Web of Science ®Google Scholar
• Blanco-Fernandez G, Fondevila-Campo C, Sanjuanbenito A, et al. Pancreatic metastases from renal cell carcinoma. Postoperative outcome after surgical treatment in a spanish multicenter study (PANMEKID). Eur J Surg Oncol. 2022;48(1):133–e141. doi: 10.1016/j.ejso.2021.08.011.
   PubMed Web of Science ®Google Scholar
• Malleo G, Salvia R, Maggino L, et al. Long-term outcomes after surgical resection of pancreatic metastases from renal clear-cell carcinoma. Ann Surg Oncol. 2021;28(6):3100–3108. doi: 10.1245/s10434-021-09649-w.
   PubMed Web of Science ®Google Scholar
• Milanetto AC, Morelli L, Di Franco G, et al. A plea for surgery in pancreatic metastases from renal cell carcinoma: indications and outcome from a multicenter surgical experience. JCM. 2020;9(10):3278. doi: 10.3390/jcm9103278.
   Google Scholar
• Grassi P, Doucet L, Giglione P, et al. Clinical impact of pancreatic metastases from renal cell carcinoma: a multicenter retrospective analysis. PLOS One. 2016;11(4):e0151662. doi: 10.1371/journal.pone.0151662.
   PubMed Web of Science ®Google Scholar
• Benhaim R, Oussoultzoglou E, Saeedi Y, et al. Pancreatic metastasis from clear cell renal cell carcinoma: outcome of an aggressive approach. Urology. 2015;85(1):135–140. doi: 10.1016/j.urology.2014.09.034.
   PubMed Web of Science ®Google Scholar
• Tosoian JJ, Cameron JL, Allaf ME, et al. Resection of isolated renal cell carcinoma metastases of the pancreas: outcomes from the Johns Hopkins Hospital. J Gastrointest Surg. 2014;18(3):542–548. doi: 10.1007/s11605-013-2278-2.
   PubMed Web of Science ®Google Scholar
• Williamson TJ, Pearson JR, Ischia J, et al. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma. BJU Int. 2016;117(4):555–562. doi: 10.1111/bju.13384.
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022;82(4):399–410. doi: 10.1016/j.eururo.2022.03.006.
   PubMed Web of Science ®Google Scholar
• Vig SVL, Zan E, Kang SK. Imaging for metastatic renal cell carcinoma. Urol Clin North Am. 2020;47(3):281–291. doi: 10.1016/j.ucl.2020.04.005.
   PubMed Web of Science ®Google Scholar
• Chiti G, Grazzini G, Cozzi D, et al. Imaging of pancreatic ­neuroendocrine neoplasms. IJERPH. 2021;18(17):8895. doi: 10.3390/ijerph18178895.
   Web of Science ®Google Scholar
• Raveenthiran S, Esler R, Yaxley J, et al. The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2019;46(11):2280–2288. doi: 10.1007/s00259-019-04432-2.
   PubMed Web of Science ®Google Scholar
• Heidsma CM, Engelsman AF, Van Dieren S, et al. Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA). Br J Surg. 2021;108(8):888–891. doi: 10.1093/bjs/znab088.
   PubMed Web of Science ®Google Scholar
• Sellner F, Thalhammer S, Klimpfinger M. Isolated pancreatic metastases of renal cell cancer: genetics and epigenetics of an unusual tumour entity. Cancers. 2022;14(6):1539. doi: 10.3390/cancers14061539.
   PubMed Web of Science ®Google Scholar
• Sellner F. Isolated pancreatic metastases of renal cell carcinoma—A paradigm of a seed and soil mechanism: a literature analysis of 1,034 observations. Front Oncol. 2020;10:709. doi: 10.3389/fonc.2020.00709.
   Google Scholar
• Azawi NH, Tesfalem H, Mosholt KSS, et al. Recurrence rates and survival in a danish cohort with renal cell carcinoma. Dan Med J. 2016;63(4):A5208.
   PubMed Web of Science ®Google Scholar
• Piltz S, Meimarakis G, Wichmann MW, et al. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg. 2002;73(4):1082–1087. doi: 10.1016/S0003-4975(01)03602-5.
   PubMed Web of Science ®Google Scholar
• Fottner A, Szalantzy M, Wirthmann L, et al. Bone metastases from renal cell carcinoma: patient survival after surgical treatment. BMC Musculoskelet Disord. 2010;11(1):145. doi: 10.1186/1471-2474-11-145.
   PubMedGoogle Scholar
• Bamias A, Escudier B, Sternberg CN, et al. Current clinical practice guidelines for the treatment of renal cell carcinoma: a systematic review and critical evaluation. Oncologist. 2017;22(6):667–679. doi: 10.1634/theoncologist.2016-0435.
   PubMed Web of Science ®Google Scholar
• Sweeney AD, Fisher WE, Wu M-F, et al. Value of pancreatic resection for cancer metastatic to the pancreas. J Surg Res. 2010;160(2):268–276. doi: 10.1016/j.jss.2008.04.012.
   PubMed Web of Science ®Google Scholar
• Mikhail M, Chua KJ, Khizir L, et al. Role of metastasectomy in the management of renal cell carcinoma. Front. Surg. 2022;9:943604. doi: 10.3389/fsurg.2022.943604.
   PubMed Web of Science ®Google Scholar
• Santoni M, Conti A, Partelli S, et al. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors. Ann Surg Oncol. 2015;22(6):2094–2100. doi: 10.1245/s10434-014-4256-7.
   PubMed Web of Science ®Google Scholar
• Lyon TD, Roussel E, Sharma V, et al. International multi-institutional characterization of the perioperative morbidity of metastasectomy for renal cell carcinoma. Eur Urol Oncol. 2023;6(1):76–83. doi: 10.1016/j.euo.2022.11.003.
   PubMed Web of Science ®Google Scholar